Many at risk for HIV despite lifesaving pill

June 11, 2018, University of Michigan
HIV infecting a human cell. Credit: NIH

Multiple barriers may stop high-risk individuals from accessing an HIV drug that can reduce the subsequent risk of infection, according to a new University of Michigan study.

Researchers outlined solutions that would help overcome barriers that make it harder for underserved populations to access pre-exposure prophylaxis (PrEP). The Centers for Disease Control and Prevention reported that nearly 40,000 people—about 43 percent of whom were black or Latino gay and bisexual men—received an HIV diagnosis in 2016.

The U-M study, published in the journal AIDS and Behavior, includes 47 peer-reviewed scholarly articles reporting data from HIV prevention and care providers, and from individuals at risk for infection. The researchers listed 31 potential solutions to 30 barriers to accessing PrEP at the patient, provider and health-system levels.

One striking to accessing PrEP is created by providers' biases toward those who most need the drug, says lead author Rogério Pinto, associate professor and associate dean for research at the U-M School of Social Work. For example, providers appear to believe that certain patients, such as transgender women and people of color, when given PrEP may be unable to consistently adhere to prescribed regimens or will stop using condoms to prevent HIV transmission.

Pinto and colleagues say that perhaps even more concerning than provider-level biased attitudes is a structural barrier referred to as the "purview paradox." On the one hand, infectious disease specialists are often trained to provide PrEP, but that they seldom actually see HIV-negative patients. On the other hand, , who care for mostly uninfected but sometimes at-risk patients, are seldom trained to provide PrEP.

Other pervasive structural obstacles—such as homophobia, transphobia and racism across systems of care—may be helped by interventions to disrupt stereotypes about potential PrEP users.

"However, patient assistance in navigating the health care system—including accessing health insurance and co-pay assistance—is a sorely needed ," Pinto said.

Some of the barriers and recommended interventions include:

To combat bias against a patient's race or sexual behaviors: Develop and deliver training to increase the provider's "cultural competency," including trans- and gender-affirming care.

In response to limited health budgets to sustain PrEP programs: Advocate among those in the medical field for expanded health insurance.

In response to legal constraints to providing PrEP for youth: Expand education, screening and referrals to PrEP services, and find improved methods to identify appropriate PrEP candidates.

The researchers note, however, that some interventions have had mixed results, in part due to not being aligned to specific barriers. Many barriers, such as interventions to lessen providers' biases and breakdowns in the health system, often target the behavior of individual instead of targeting providers and health systems, they say.

"The key message from this review is that barriers to PrEP implementation cut across patient, provider and health-system levels, and that multiple interventions, mapped onto specific barriers, ought to be used," Pinto said.

In addition, he says that without attention to the ways structural factors affect individuals within care systems, PrEP implementation "may actually reinforce existing inequities that place the overwhelming burden of the HIV epidemic on more vulnerable groups."

Explore further: Researcher identifies barriers impacting PrEP use among Latino gay and bisexual men

More information: Rogério M. Pinto et al. Improving PrEP Implementation Through Multilevel Interventions: A Synthesis of the Literature, AIDS and Behavior (2018). DOI: 10.1007/s10461-018-2184-4

Related Stories

Researcher identifies barriers impacting PrEP use among Latino gay and bisexual men

May 9, 2018
A new study led by a UTSA researcher examines the social perceptions of Pre-Exposure Prophylaxis (PrEP), a medication to prevent HIV, among gay and bisexual men in Texas.

Fewer men who have sex with men are using condoms when taking PrEP, and that's OK

June 7, 2018
Fewer gay and bisexual men are using condoms while taking PrEP, the antiretroviral pill that prevents HIV, according to research published today in the The Lancet medical journal.

Providers who prescribe PrEP don't see most patients increasing risky sexual behavior

April 26, 2017
A new study examining medical provider attitudes toward prescribing PrEP to prevent HIV found that those who already prescribe it do not see widespread increases in risky sexual behavior among their patients as a result. ...

Study finds barriers to accessing HIV prevention pill

September 13, 2016
APLA Health, in partnership with the California HIV/AIDS Research Program (CHRP) of the University of California, today (Sept. 12) released a new report on pre-exposure prophylaxis (PrEP) titled "Addressing PrEP Disparities ...

Breaking down barriers to accessing PrEP for men who have sex with men

September 12, 2017
A new study has shown that barriers preventing men who have sex with men (MSM) from establishing nonjudgmental relationships with primary care providers may limit access to preexposure prophylaxis (PrEP) to prevent HIV infection. ...

Most gay men not aware of treatment to protect them from HIV

October 5, 2016
Only four in 10 gay and bisexual men in Baltimore without HIV are aware that pre-exposure prophylaxis medication (PrEP) may significantly reduce their risk of contracting the virus, even those who had recently visited a doctor ...

Recommended for you

Proof-of-concept HIV immunotherapy study passes Phase 1 safety trial

September 21, 2018
Preliminary results from a phase I clinical trial have demonstrated the safety and tolerability of a cell therapy involving the ex vivo expansion of T cells and their subsequent infusion into HIV-infected individuals previously ...

FRESH program combines basic science with social benefits for women at risk of HIV

September 14, 2018
A program established by investigators from the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard is addressing the persistently elevated risk of HIV infection among young women in South Africa from ...

New study finds HIV outbreak in Indiana could have been prevented

September 13, 2018
An HIV outbreak among people who inject drugs in Indiana from 2011 to 2015 could have been avoided if the state's top health and elected officials had acted sooner on warnings, a new study by the Yale School of Public Health ...

Largest study of 'post-treatment controllers' reveals clues about HIV remission

September 13, 2018
Most HIV patients need to take daily anti-retroviral therapy—if they suspend treatment, HIV will rebound within 3-4 weeks. But clinical trials have revealed that a small fraction of patients can stop taking medications ...

Very few sexually active gay and bisexual men use prophylactic drug to prevent HIV transmission, study finds

September 12, 2018
Only 4 percent of sexually active gay and bisexual men in the United States use Truvada, a highly effective medication used to prevent the transmission of HIV, according to the results of a first-of-its-kind study.

Special antibodies could lead to HIV vaccine

September 10, 2018
Around one percent of people infected with HIV produce antibodies that block most strains of the virus. These broadly acting antibodies provide the key to developing an effective vaccine against HIV. Researchers from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.